US NIH National Institute of Diabetes and Digestive and Kidney Diseases: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)

This opportunity uses the R01 Research Project Grant funding mechanism.

This scheme aims to expand the number of genes and range of IBD-related phenotypes and physiological domains under study by means of collaborations of the IBDGC with investigators with expertise complementary to that of their own members. Multi-site clinical trials are not eligible.

Funding & Duration

Application budgets are each limited to USD $200,000 (approx. AUD $278,000) in direct costs per year for a maximum period of three years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.